Last reviewed · How we verify
NCT06256757
Safety and Validity of Extracorporeal Fenestration and in Situ Fenestration in Patients With Aortic Disease Involving the Left Subclavian Artery
NA trial testing fenestration in Aortic Dissection Aneurysm in 170 participants. Not yet recruiting.
30 May 2028
Quick facts
| Lead sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 170 |
| Start date | 1 May 2024 |
| Primary completion | 30 May 2028 |
| Estimated completion | 30 April 2029 |
Drugs / interventions tested
- fenestration
Conditions studied
- Aortic Dissection Aneurysm — all drugs for Aortic Dissection Aneurysm →
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Who can join
Adults 18 to 80, any sex, with Aortic Dissection Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial aims to demonstrate the safety and validity of extracorporeal fenestration and in situ fenestration in patients with aortic disease involving the left subclavian artery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and validity of extracorporeal fenestration and in situ fenestration in patients with aortic disease involving the left subclavian artery: a prospective, single-center, randomized controlled study.
Jia X, Wu J, Ding C, Lou Y. · · 2025 · PMID 39885531 · DOI 10.1186/s13063-025-08746-5
Verify or expand the search:
- PubMed search for NCT06256757
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Dissection Aneurysm
Currently open trials in the same condition.
- NCT06062524 — Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System · NA · recruiting
Other The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials
Trials by the same sponsor.
- NCT07336888 — A Study on the Application of Positive Psychological Counseling Based on "Dou Bao" Software in Patients With Post-stroke · NA · not yet recruiting
- NCT07375862 — Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostas · Phase 2 · not yet recruiting
- NCT07301437 — RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients. · Phase 4 · not yet recruiting
- NCT07289750 — The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients · Phase 4 · not yet recruiting
- NCT07512791 — Effect of Bagua Auriculotherapy on Pain in Patients Undergoing Hysteroscopy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06256757 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256757.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing